| P2093 | author name string | Uwe von Fritschen | |
| | Christine Solbach | |
| | Eva Maria Fallenberg | |
| | Julian Kricheldorff | |
| | Christoph Rancsó | |
| | Claudia Gerber-Schäfer | |
| P2860 | cites work | MSCs and inflammation: new insights into the potential association between ALCL and breast implants | Q38787765 |
| | Breast implant associated Anaplastic Large Cell Lymphoma in Australia and New Zealand - high surface area textured implants are associated with increased risk | Q38798244 |
| | Cancer risk from orthopedic prostheses. | Q38950452 |
| | Global Adverse Event Reports of Breast Implant-Associated ALCL: An International Review of 40 Government Authority Databases. | Q38980992 |
| | U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma | Q38980998 |
| | Discussion: Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma | Q40661913 |
| | Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma | Q40786467 |
| | Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants: Report of the First Case | Q41495207 |
| | Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity | Q42392731 |
| | Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast. | Q47207270 |
| | Implant-associated primary anaplastic large-cell lymphoma with simultaneous involvement of bilateral breast capsules | Q47616004 |
| | Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant | Q73576115 |
| | Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases | Q84187567 |
| | How to Diagnose and Treat Breast Implant-Associated Anaplastic Large Cell Lymphoma | Q88212540 |
| | The biology and management of systemic anaplastic large cell lymphoma | Q27009497 |
| | Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials | Q28245893 |
| | Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study | Q33401346 |
| | NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma | Q34550971 |
| | Anaplastic large-cell lymphoma in women with breast implants | Q34872736 |
| | Breast Implant-associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process | Q35069314 |
| | Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma | Q36914387 |
| | The 2016 revision of the World Health Organization classification of lymphoid neoplasms | Q36920426 |
| | Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis | Q37054581 |
| | Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. | Q37423032 |
| | Soft Tissue Anaplastic Large T-Cell Lymphoma Associated with a Metallic Orthopedic Implant: Case Report and Review of the Current Literature | Q37792612 |
| | Anaplastic large cell lymphoma and breast implants: a systematic review | Q37848031 |
| | Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases | Q38067025 |
| | Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients | Q38235161 |
| | Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases | Q38285756 |
| | Silicone implants and lymphoma: The role of inflammation | Q38578692 |
| | Coming of Age: Breast Implant-Associated Anaplastic Large Cell Lymphoma After 18 Years of Investigation | Q38593207 |
| | Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. | Q38735573 |
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 628-635 | |
| P577 | publication date | 2018-09-01 | |
| P1433 | published in | Deutsches Ärzteblatt international | Q27722165 |
| P1476 | title | Breast Implant-Associated Lymphoma | |
| P478 | volume | 115 | |